Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
steroids
Biotech
Lyra Therapeutics wants a $58M IPO
Ear, nose and throat diseases biotech Lyra Therapeutics aims to drive through the coronavirus market volatility and gun for a $58 million IPO.
Ben Adams
Mar 9, 2020 8:25am
Spruce nets $88M to push rare disease drug into late-stage trial
Feb 20, 2020 9:55am
Spruce scores phase 2a win for rare disease drug, preps for 2020
Sep 19, 2019 8:00am
